L

Lucid Diagnostics Inc
NASDAQ:LUCD

Watchlist Manager
Lucid Diagnostics Inc
NASDAQ:LUCD
Watchlist
Price: 1.2 USD -4% Market Closed
Market Cap: $157.1m

Relative Value

The Relative Value of one LUCD stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.2 USD, Lucid Diagnostics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LUCD Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

LUCD Competitors Multiples
Lucid Diagnostics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lucid Diagnostics Inc
NASDAQ:LUCD
157.1m USD 35.7 -2.4 -2.8 -2.8
US
Abbott Laboratories
NYSE:ABT
180.7B USD 4.1 27.7 15.9 21.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.6B USD 16.6 58.7 44.5 54.7
US
Stryker Corp
NYSE:SYK
125.7B USD 5 38.7 19.8 24
IE
Medtronic PLC
NYSE:MDT
111.1B USD 3.1 24.1 13.3 19.4
US
Boston Scientific Corp
NYSE:BSX
101.1B USD 5 34.9 20.5 27.6
DE
Siemens Healthineers AG
XETRA:SHL
41.4B EUR 1.8 19.6 11 15.5
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD 7.8 44.2 24.3 26.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.5B USD 10.6 42.9 30.4 33.7
US
Becton Dickinson and Co
NYSE:BDX
44.4B USD 2 25.3 10 16.9
US
Resmed Inc
NYSE:RMD
33.2B USD 6.2 22.4 15.7 17.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
L
Lucid Diagnostics Inc
NASDAQ:LUCD
Average EV/EBITDA: 20.5
Negative Multiple: -2.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
15.9
11%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
44.5
23%
1.9
US
Stryker Corp
NYSE:SYK
19.8
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.3
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.5
18%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
11
10%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
24.3
14%
1.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.4
11%
2.8
US
Becton Dickinson and Co
NYSE:BDX
10
1%
10
US
Resmed Inc
NYSE:RMD
15.7
11%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
L
Lucid Diagnostics Inc
NASDAQ:LUCD
Average EV/EBIT: 25.8
Negative Multiple: -2.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.8
18%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
54.7
25%
2.2
US
Stryker Corp
NYSE:SYK
24
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.4
17%
1.1
US
Boston Scientific Corp
NYSE:BSX
27.6
25%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
15.5
15%
1
US
Edwards Lifesciences Corp
NYSE:EW
26.6
15%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.7
12%
2.8
US
Becton Dickinson and Co
NYSE:BDX
16.9
15%
1.1
US
Resmed Inc
NYSE:RMD
17.5
12%
1.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett